References
- Fibromyalgia. Atlanta, GA: American College of Rheumatology. Published March 2019. https://www.rheumatology.org/I-Am-A/Patient-Caregiver/Diseases-Conditions/Fibromyalgia. Accessed August 10, 2020.
- Smith HS, Barkin RL. Fibromyalgia syndrome: a discussion of the syndrome and pharmacotherapy. Am J Ther. 2010;17(4):418–39. doi:https://doi.org/10.1097/MJT.0b013e3181df8e1b.
- Chinn S, Caldwell W, Gritsenko K. Fibromyalgia pathogenesis and treatment options update. Curr Pain Headache Rep. 2016;20(4):25. doi:https://doi.org/10.1007/s11916-016-0556-x.
- Bigatti SM, Hernandez AM, Cronan TA, Rand KL. Sleep disturbances in fibromyalgia syndrome: relationship to pain and depression. Arthritis Rheum. 2008;59(7):961–7. doi:https://doi.org/10.1002/art.23828.
- Russell IJ. The promise of substance P inhibitors in fibromyalgia. Rheum Dis Clin North Am. 2002;28(2):329–42. doi:https://doi.org/10.1016/s0889-857x(01)00006-0.
- Lembeck F, Gamse R. Substance P in peripheral sensory processes. Ciba Found Symp 91. 1982;35–54. doi:https://doi.org/10.1002/9780470720738.ch4.
- Schwarz MJ, Späth M, Müller-Bardorff H, Pongratz DE, Bondy B, Ackenheil M. Relationship of substance P, 5-hydroxyindole acetic acid and tryptophan in serum of fibromyalgia patients. Neurosci Lett. 1999;259(3):196–8. doi:https://doi.org/10.1016/s0304-3940(98)00937-9.
- Theoharides TC, Tsilioni I, Bawazeer M. Mast Cells, Neuroinflammation and Pain in Fibromyalgia Syndrome. Front Cell Neurosci. 2019;13:353. Epub 2019/08/02. doi:https://doi.org/10.3389/fncel.2019.00353.
- Wallace DJ, Linker-Israeli M, Hallegua D, Silverman S, Silver D, Weisman MH. Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study. Rheumatology (Oxford). 2001;40(7):743–9. doi:https://doi.org/10.1093/rheumatology/40.7.743.
- Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1–34. Epub 2009/07/23. doi:https://doi.org/10.1016/j.jclinepi.2009.06.006.
- McCarty DJ, Csuka M, Mccarthy G, Trotter D. Treatment of pain due to fibromyalgia with topical capsaicin: a pilot study. Semin Arthritis Rheum. 1994;23(6):41–7. doi:https://doi.org/10.1016/S0049-0172(10)80025-3.
- Casanueva B, Rodero B, Quintial C, Llorca J, González-Gay MA. Short-term efficacy of topical capsaicin therapy in severely affected fibromyalgia patients. Rheumatol Int. 2013;33(10):2665–70. Epub 2012/07/28. doi:https://doi.org/10.1007/s00296-012-2490-5.
- Rico-Villademoros F, Slim M, Calandre EP. Amitriptyline for the treatment of fibromyalgia: a comprehensive review. Expert Rev Neurother. 2015;15(10):1123–50. Epub 2015/09/22. doi:https://doi.org/10.1586/14737175.2015.1091726.
- Crofford LJ, Mease PJ, Simpson SL, Young JP, Martin SA, Haig GM, Sharma U. Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin. Pain. 2008;136(3):419–31. Epub 2008/04/08. doi:https://doi.org/10.1016/j.pain.2008.02.027.
- Walitt B, Urrútia G, Nishishinya MB, Cantrell SE, Häuser W. Selective serotonin reuptake inhibitors for fibromyalgia syndrome. Cochrane Database Syst Rev. 2015;(6):CD011735. Epub 2015/06/05. doi:https://doi.org/10.1002/14651858.CD011735.
- Welsch P, Üçeyler N, Klose P, Walitt B, Häuser W. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia. Cochrane Database Syst Rev. 2018;2:CD010292. Epub 2018/02/28. doi:https://doi.org/10.1002/14651858.CD010292.
- Romano GF, Tomassi S, Russell A, Mondelli V, Pariante CM. Fibromyalgia and chronic fatigue: the underlying biology and related theoretical issues. Adv Psychosom Med. 2015;34:61–77. Epub 2015/03/30. doi:https://doi.org/10.1159/000369085.
- Thomson Reuters Micromedex: RED BOOK Drug References. IBM Corporation; 2021. https://www.ibm.com/products/micromedex-red-book?cm_sp=Scheduler-_-CopyChng2-_-C. Accessed November 8, 2020
- Wolfe F, Clauw DJ, Fitzcharles M-A, Goldenberg DL, Häuser W, Katz RL, Mease PJ, Russell AS, Russell IJ, Walitt B, et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016;46(3):319–29. doi:https://doi.org/10.1016/j.semarthrit.2016.08.012.
- Macfarlane GJ, Kronisch C, Dean LE, Atzeni F, Häuser W, Fluß E, Choy E, Kosek E, Amris K, Branco J, et al. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis. 2017;76(2):318–28. doi:https://doi.org/10.1136/annrheumdis-2016-209724.]